Filing Details

Accession Number:
0001140361-17-032607
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-17 16:32:57
Reporting Period:
2017-08-15
Filing Date:
2017-08-17
Accepted Time:
2017-08-17 16:32:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1294935 M Jerome Hauer 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-15 5,153 $25.47 29,421 No 4 A Direct
Common Stock Disposition 2017-08-15 10,776 $35.83 18,645 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-08-15 5,153 $0.00 5,153 $25.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,152 2022-01-21 No 4 M Direct
Footnotes
  1. Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.70 to $36.05, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.